Search research articles
Contact Us
Filters
Showing results (201-210 of 213) with videos related to
Page
of 22
Sort By:
International Journal of Medical Informatics
|
July 31, 2025
A multi-task deep sequential neural network for IgA nephropathy Oxford classification and prognosis prediction
Sai Pan, Yibing Fu, Lai Jiang, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
June 15, 2020
Efficacy and safety of Abelmoschus manihot for IgA nephropathy: A multicenter randomized clinical trial
Ping Li, Hongli Lin, Zhaohui Ni, et al.
Journal of Diabetes
|
October 13, 2015
Telmisartan combined with probucol effectively reduces urinary protein in patients with type 2 diabetes: A randomized double-blind placebo-controlled multicenter clinical study
Hanyu Zhu, Xiangmei Chen, Guangyan Cai, et al.
Journal of Ethnopharmacology
|
March 17, 2025
A randomized, double-blind, placebo-controlled trial of Wenshenyang decoction for the improvement of renal function and kidney-yang deficiency syndrome in patients with CKD
Ge Jin, Wenge Li, Luying Sun, et al.
Journal of Autoimmunity
|
November 3, 2018
The landscape and diagnostic potential of T and B cell repertoire in Immunoglobulin A Nephropathy
Chen Huang, Xuemei Li, Jinghua Wu, et al.
BMC Nephrology
|
January 22, 2013
Association between family members of dialysis patients and chronic kidney disease: a multicenter study in China
Xianglei Kong, Li Liu, Li Zuo, et al.
Chronic Diseases and Translational Medicine
|
July 1, 2022
Efficacy and safety of darbepoetin alfa injection replacing epoetin alfa injection for the treatment of renal anemia in Chinese hemodialysis patients: A randomized, open-label, parallel-group, noninferiority phase III trial
Bicheng Liu, Nan Chen, Jinghong Zhao, et al.
Chronic Diseases and Translational Medicine
|
May 27, 2022
Darbepoetin alfa injection versus epoetin alfa injection for treating anemia of Chinese hemodialysis patients with chronic kidney failure: A randomized, open-label, parallel-group, non-inferiority Phase III trail
Nan Chen, Changying Xing, Jianying Niu, et al.
Clinical Epigenetics
|
July 31, 2024
DNA methylation and whole-genome transcription analysis in CD4<sup>+</sup> T cells from systemic lupus erythematosus patients with or without renal damage
Xiaomin Liu, Siyu Zhou, Mengjie Huang, et al.
Kidney & Blood Pressure Research
|
November 15, 2017
Risk Factor Analysis for AKI Including Laboratory Indicators: a Nationwide Multicenter Study of Hospitalized Patients
Sasa Nie, Zhe Feng, Li Tang, et al.
Page
of 22
Search research articles
Search
Showing results (201-210 of 213) with videos related to
Sort By:
Page
of 22
International Journal of Medical Informatics
|
July 31, 2025
A multi-task deep sequential neural network for IgA nephropathy Oxford classification and prognosis prediction
Sai Pan, Yibing Fu, Lai Jiang, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
June 15, 2020
Efficacy and safety of Abelmoschus manihot for IgA nephropathy: A multicenter randomized clinical trial
Ping Li, Hongli Lin, Zhaohui Ni, et al.
Journal of Diabetes
|
October 13, 2015
Telmisartan combined with probucol effectively reduces urinary protein in patients with type 2 diabetes: A randomized double-blind placebo-controlled multicenter clinical study
Hanyu Zhu, Xiangmei Chen, Guangyan Cai, et al.
Journal of Ethnopharmacology
|
March 17, 2025
A randomized, double-blind, placebo-controlled trial of Wenshenyang decoction for the improvement of renal function and kidney-yang deficiency syndrome in patients with CKD
Ge Jin, Wenge Li, Luying Sun, et al.
Journal of Autoimmunity
|
November 3, 2018
The landscape and diagnostic potential of T and B cell repertoire in Immunoglobulin A Nephropathy
Chen Huang, Xuemei Li, Jinghua Wu, et al.
BMC Nephrology
|
January 22, 2013
Association between family members of dialysis patients and chronic kidney disease: a multicenter study in China
Xianglei Kong, Li Liu, Li Zuo, et al.
Chronic Diseases and Translational Medicine
|
July 1, 2022
Efficacy and safety of darbepoetin alfa injection replacing epoetin alfa injection for the treatment of renal anemia in Chinese hemodialysis patients: A randomized, open-label, parallel-group, noninferiority phase III trial
Bicheng Liu, Nan Chen, Jinghong Zhao, et al.
Chronic Diseases and Translational Medicine
|
May 27, 2022
Darbepoetin alfa injection versus epoetin alfa injection for treating anemia of Chinese hemodialysis patients with chronic kidney failure: A randomized, open-label, parallel-group, non-inferiority Phase III trail
Nan Chen, Changying Xing, Jianying Niu, et al.
Clinical Epigenetics
|
July 31, 2024
DNA methylation and whole-genome transcription analysis in CD4<sup>+</sup> T cells from systemic lupus erythematosus patients with or without renal damage
Xiaomin Liu, Siyu Zhou, Mengjie Huang, et al.
Kidney & Blood Pressure Research
|
November 15, 2017
Risk Factor Analysis for AKI Including Laboratory Indicators: a Nationwide Multicenter Study of Hospitalized Patients
Sasa Nie, Zhe Feng, Li Tang, et al.
Page
of 22